A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis
PHASE2
The objectives of Sub-Study 1 are to evaluate the efficacy, safety, and pha...
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment
PHASE3
The objective of Study M15-991 is to evaluate the efficacy and safety of ri...